Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes

International Journal of Experimental Pathology

Volumn 93, Issue 2, 2012, Pages 148-156

  Davies, Maria ^a   Prime, Stephen S ^a   Eveson, John W ^a   Price, Nicky ^a   Ganapathy, Anu ^a   D'Mello, Anita ^a   Paterson, Ian C ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Invasion; Isoform; Keratinocytes; SCC; TGF

Indexed keywords

RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FOLLOW UP; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN METASTASIS; TUMOR VOLUME;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84858211273     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00806.x     Document Type: Article

References (28)

1. Adorno M., Cordenonsi M., Montagner M. et al. (2009) A mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137, 87-98.
2. Beisner J., Buck M.B., Fritz P. et al. (2006) A novel functional polymorphism in the transforming growth factor-β2 gene promoter and tumour progression in breast cancer. Cancer Res. 66, 7554-7561.
3. Cui W., Fowlis D.J., Bryson S. et al. (1996) TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542.
4. Davies M., Prime S.S., Stone A.M. et al. (1997) Overexpression of autocrine TGF-β1 suppresses the growth of spindle epithelial cells in vitro and in vivo in the rat 4-NQO model of oral carcinogenesis. Int. J. Cancer 73, 68-74.
5. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell. Biochem. 95, 918-931.
6. Fahey M.S., Paterson I.C., Stone A. et al. (1996) Dysregulation of autocrine TGF-β isoform production and ligand responses in tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Br. J. Cancer 74, 1074-1080.
7. Fusenig N.E. & Boukamp P. (1998) Multiple stages and genetic alterations in immortalization, malignant transformation, and tumour progression of human skin keratinocytes. Mol. Carcinog. 23, 144-158.
8. Ganapathy A., Paterson I.C., Prime S.S. et al. (2010) TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1. Cancer Lett. 298, 107-118.
9. Gold L.I., Jussila T., Fusenig N.E., Stenbäck F. (2000) TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis. J. Pathol. 190, 579-588.
10. Graycar J.L., Miller D.A., Arrick B.A., Lyons R.M., Moses H.L., Derynck R. (1989) Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol. Endocrinol. 3, 1977-1986.
11. Han G., Lu S.-L., Li A.G. et al. (2005) Distinct mechanisms of TGF-β1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J. Clin. Invest. 115, 1714-1723.
12. Hannigan A., Smith P., Kalna G. et al. (2010) Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J. Clin. Invest. 120, 2842-2857.
13. Heldin C.H., Landstrom M., Moustaks A. (2009) Mechanisms of TGF-β signaling to growth arrest, apoptosis and epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 21, 166-176.
14. Korpal M. & Kang Y. (2010) Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. Eur. J. Cancer 46, 1232-1240.
15. Laverty H.G., Wakefield L.M., Occleston N.L., Ferguson M.W.J. (2009) TGF-β3 and cancer: a review. Cytokine Growth Factor Rev. 20, 305-317.
16. Lee M.K., Pardoux C., Hall M.C. et al. (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26, 3957-3967.
17. Letterio J.J. & Bottinger E.P. (1998) TGF-beta knockout and dominant-negative transgenic mice. Miner. Electrolyte Metab. 24, 161-167.
18. Massague J. (2008) TGF-β in cancer. Cell 134, 220-227.
19. Meulmeester E. & ten Dijke P. (2011) The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205-218.
20. Nystrom M.L., Thomas G.J., Hart I.R., Stone M., McKenzie I.C., Marshall J.F. (2005) Development of a quantitative method to analyse tumorcell invasion in organotypic culture. J. Pathol. 205, 468-475.
21. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. (1991) Immunohistochemical localization of TGF-β1, TGF-β2 and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115, 1091-1105.
22. Portella G., Cumming S.A., Liddell J. et al. (1998) Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9, 393-404.
23. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 39, 871-890.
24. Tobin S.W., Douville K., Benbow U., Brinckerhoff C.E., Memoli V.A., Arrick B.A. (2002) Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Oncogene 21, 108-118.
25. Tsamandas A.C., Kardamakis D., Ravazoula P. et al. (2004) The potential role of TGFβ1, TGFβ2, and TGFβ3 protein expression in colorectal carcinomas. Strahlenther. Onkol. 180, 201-208.
26. Vagenas K., Spyropoulos C., Gavala V., Tsmandas A.C. (2007) TGF-β1, TGF-β2, and TGFβ3 protein expression in gastric ccarcinomas: correlation with prognostic factors and patient survival. J. Surg. Res. 139, 182-188.
27. Yap L.F., Jenei V., Robinson C.M. et al. (2009) Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Oncogene, 28, 2524-2534.
28. Zhang Y.E. (2009) Non Smad pathways in TGF-β signalling. Cell Res. 19, 128-139.